Overview

Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Saturno II association on the control of ocular inflammation post-phacoemulsification
Phase:
Phase 2
Details
Lead Sponsor:
EMS
Treatments:
Dexamethasone
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination